Efficacy of Imatinib in Patients with Platelet-Derived Growth Factor Receptor Alpha–Mutated Gastrointestinal Stromal Tumors

PURPOSE: The incidence of gastrointestinal stromal tumors (GISTs) harboring platelet-derived growth factor receptor alpha (PDGFRA) mutations is low, therefore further investigation of the efficacy of imatinib in this subgroup was needed. MATERIALS AND METHODS: Patients with PDGFRA-mutant GISTs who r...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoo, Changhoon, Ryu, Min-Hee, Jo, Jungmin, Park, Inkeun, Ryoo, Baek-Yeol, Kang, Yoon-Koo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843750/
https://www.ncbi.nlm.nih.gov/pubmed/26130666
http://dx.doi.org/10.4143/crt.2015.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843750/
https://www.ncbi.nlm.nih.gov/pubmed/26130666
http://dx.doi.org/10.4143/crt.2015.015

Ejemplares similares